Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease.
Balmiki RayBryan MaloneyKumar SambamurtiHanuma K KarnatiPeter T NelsonNigel H GreigDebomoy K LahiriPublished in: Translational psychiatry (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.